The present invention relates to compounds according to the general formula (I)
1
wherein R
1
, A, B, Q, T, W and X have the meanings given in the description.
These compounds are useful for the manufacture of a medicament for the treatment of insulin resistance, type 2 diabetes, metabolic syndrome, lipid disorders or cardiovasular disease or for providing an anti-lipolytic effect.
本发明涉及符合通用公式(I)1的化合物,其中R1、A、B、Q、T、W和X的含义如描述中所述。这些化合物可用于制造用于治疗
胰岛素抵抗、2型糖尿病、代谢综合征、脂质紊乱或心血管疾病的药物,或者用于提供抗脂解效应。